Interview with Pulmonologists for Insights on Idiopathic Pulmonary Fibrosis (IPF)

  • Dr. Salil Bendre
  • Dr. Desh Deepak
  • Dr. Viral Nanda

Abstract

The untimely demise of renowned percussionist Zakir Hussain has refocused attention to Idiopathic Pulmonary Fibrosis (IPF), a chronic and progressive lung disease of unknown origin. Leading pulmonologists Dr. Salil Bendre, Dr. Desh Deepak, and Dr. Viral Nanda have addressed key questions posed by The Indian Practitioner to raise awareness about this condition. Their insights provide an in-depth understanding of the disease, including its risk factors, symptoms, diagnostic tools, treatment modalities, and the importance of a multidisciplinary approach. Additionally, they emphasize the need for further research into innovative therapies and healthcare policies to improve patient outcomes and extend life expectancy in individuals affected by IPF.

Published
2025-02-13
How to Cite
Dr. Salil Bendre, Dr. Desh Deepak, & Dr. Viral Nanda. (2025). Interview with Pulmonologists for Insights on Idiopathic Pulmonary Fibrosis (IPF). The Indian Practitioner, 78(01), 26-30. Retrieved from https://articles.theindianpractitioner.com/index.php/tip/article/view/1847